Global Veterinary Diagnostic Market Size By Product (Instruments, Consumables), By End-use (Hospitals, Diagnostic Imaging Centers) By Region (U.S., Canada, Mexico, Rest of North America, France, UK, Germany, Spain, Italy, Nordic Countries, Benelux Union, Rest of Europe, China, Japan, India, New Zealand, Australia, South Korea, Southeast Asia, Rest of Asia Pacific, Saudi Arabia, UAE, Egypt, Kuwait, South Africa, Rest of MEA, Brazil, Argentina, Rest of Latin America) – Global Insights, Growth, Size, Comparative Analysis, Trends and Forecast, 2019 – 2027

1.    Market Scope

1.1. Market Segmentation

1.2. Years Considered

1.2.1. Historic Years: 2013 - 2017

1.2.2. Base Year: 2018

1.2.3. Forecast Years: 2019 – 2027

2.    Key Target Audiences

3.    Research Methodology

3.1. Primary Research

3.1.1. Research Questionnaire

3.1.2. Global Percentage Breakdown

3.1.3. Primary Interviews: Key Opinion Leaders (KOLs)

3.2. Secondary Research

3.2.1. Paid Databases

3.2.2. Secondary Sources

3.3. Market Size Estimates

3.3.1. Top-Down Approach

3.3.2. Bottom-Up Approach

3.4. Data Triangulation Methodology

3.5. Research Assumptions

4.    Recommendations and Insights from AMI’s Perspective**

5.    Holistic Overview of Veterinary Diagnostic Market

6.    Market Synopsis:  Veterinary Diagnostic Market

7.    Veterinary Diagnostic Market Analysis: Qualitative Perspective

7.1. Introduction

7.1.1. Product Definition

7.1.2. Industry Development

7.2. Market Dynamics

7.2.1. Drivers

7.2.2. Restraints

7.2.3. Opportunities

7.3. Trends in Veterinary Diagnostic Market

7.4. Market Determinants Radar Chart

7.5. Macro-Economic and Micro-Economic Indicators: Veterinary Diagnostic Market

7.6. Industry Gross Margin Overview

7.7. Porter’s Five Force Analysis

8.    Global Veterinary Diagnostic Market Analysis and Forecasts, 2019 – 2027

8.1. Overview

8.1.1. Global Veterinary Diagnostic Market Revenue (US$ Mn)

8.2. Global Veterinary Diagnostic Market Revenue (US$ Mn) and Forecasts, By Product

8.2.1. Instruments

8.2.1.1.    Definition

8.2.1.2.    Market Penetration, 2018

8.2.1.3.    Market Estimation, 2013 – 2018

8.2.1.4.    Market Forecast, 2019 – 2027

8.2.1.5.    Compound Annual Growth Rate (CAGR)

8.2.1.6.    Regional Bifurcation

8.2.1.6.1.    North America

8.2.1.6.1.1. Market Estimation, 2013 – 2018

8.2.1.6.1.2. Market Forecast, 2019 – 2027

8.2.1.6.2.    Europe

8.2.1.6.2.1. Market Estimation, 2013 – 2018

8.2.1.6.2.2. Market Forecast, 2019 – 2027

8.2.1.6.3.    Asia Pacific

8.2.1.6.3.1. Market Estimation, 2013 – 2018

8.2.1.6.3.2. Market Forecast, 2019 – 2027

8.2.1.6.4.    Middle East and Africa

8.2.1.6.4.1. Market Estimation, 2013 – 2018

8.2.1.6.4.2. Market Forecast, 2019 – 2027

8.2.1.6.5.    Latin America

8.2.1.6.5.1. Market Estimation, 2013 – 2018

8.2.1.6.5.2. Market Forecast, 2019 – 2027

8.2.2. Consumables

8.2.2.1.    Definition

8.2.2.2.    Market Penetration, 2018

8.2.2.3.    Market Estimation, 2013 – 2018

8.2.2.4.    Market Forecast, 2019 – 2027

8.2.2.5.    Compound Annual Growth Rate (CAGR)

8.2.2.6.    Regional Bifurcation

8.2.2.6.1.    North America

8.2.2.6.1.1. Market Estimation, 2013 – 2018

8.2.2.6.1.2. Market Forecast, 2019 – 2027

8.2.2.6.2.    Europe

8.2.2.6.2.1. Market Estimation, 2013 – 2018

8.2.2.6.2.2. Market Forecast, 2019 – 2027

8.2.2.6.3.    Asia Pacific

8.2.2.6.3.1. Market Estimation, 2013 – 2018

8.2.2.6.3.2. Market Forecast, 2019 – 2027

8.2.2.6.4.    Middle East and Africa

8.2.2.6.4.1. Market Estimation, 2013 – 2018

8.2.2.6.4.2. Market Forecast, 2019 – 2027

8.2.2.6.5.    Latin America

8.2.2.6.5.1. Market Estimation, 2013 – 2018

8.2.2.6.5.2. Market Forecast, 2019 – 2027

8.3. Key Segment for Channeling Investments

8.3.1. By Product

9.    Global Veterinary Diagnostic Market Analysis and Forecasts, 2019 – 2027

9.1. Overview

9.2. Global Veterinary Diagnostic Market Revenue (US$ Mn) and Forecasts, By Technology

9.2.1. Immunodiagnostic (Definition, Market Penetration (2018), Market Estimation (2013 – 2018), Market Forecast (2019 – 2027), Compound Annual Growth Rate (CAGR), Regional Bifurcation (North America, Europe, Asia Pacific, Middle East and Africa, Latin America) and Information on Lateral flow assays, ELISA, Immunoassay analyzers, Others)

9.2.1.1.    Lateral flow assays

9.2.1.2.    ELISA

9.2.1.3.    Immunoassay analyzers

9.2.1.4.    Others

9.2.2. Molecular Diagnostic (Definition, Market Penetration (2018), Market Estimation (2013 – 2018), Market Forecast (2019 – 2027), Compound Annual Growth Rate (CAGR), Regional Bifurcation (North America, Europe, Asia Pacific, Middle East and Africa, Latin America) and Information on Polymerase Chain Reaction (PCR), Microarrays , Others)

9.2.2.1.    Polymerase Chain Reaction (PCR)

9.2.2.2.    Microarrays

9.2.2.3.    Others

9.2.3. Hematology (Definition, Market Penetration (2018), Market Estimation (2013 – 2018), Market Forecast (2019 – 2027), Compound Annual Growth Rate (CAGR), Regional Bifurcation (North America, Europe, Asia Pacific, Middle East and Africa, Latin America) and Information on Cartridges, Analyzers)

9.2.3.1.    Cartridges

9.2.3.2.    Analyzers

9.2.4. Clinical Chemistry (Definition, Market Penetration (2018), Market Estimation (2013 – 2018), Market Forecast (2019 – 2027), Compound Annual Growth Rate (CAGR), Regional Bifurcation (North America, Europe, Asia Pacific, Middle East and Africa, Latin America) and Information on Clinical Chemistry Analyzers, Glucose monitoring, Blood gas and electrolyte analysis)

9.2.4.1.    Clinical Chemistry Analyzers

9.2.4.2.    Glucose monitoring

9.2.4.3.    Blood gas and electrolyte analysis

9.2.5. Others

9.2.5.1.    Definition

9.2.5.2.    Market Penetration, 2018

9.2.5.3.    Market Estimation, 2013 – 2018

9.2.5.4.    Market Forecast, 2019 – 2027

9.2.5.5.    Compound Annual Growth Rate (CAGR)

9.2.5.6.    Regional Bifurcation

9.2.5.6.1.    North America

9.2.5.6.1.1. Market Estimation, 2013 – 2018

9.2.5.6.1.2. Market Forecast, 2019 – 2027

9.2.5.6.2.    Europe

9.2.5.6.2.1. Market Estimation, 2013 – 2018

9.2.5.6.2.2. Market Forecast, 2019 – 2027

9.2.5.6.3.    Asia Pacific

9.2.5.6.3.1. Market Estimation, 2013 – 2018

9.2.5.6.3.2. Market Forecast, 2019 – 2027

9.2.5.6.4.    Middle East and Africa

9.2.5.6.4.1. Market Estimation, 2013 – 2018

9.2.5.6.4.2. Market Forecast, 2019 – 2027

9.2.5.6.5.    Latin America

9.2.5.6.5.1. Market Estimation, 2013 – 2018

9.2.5.6.5.2. Market Forecast, 2019 – 2027

9.3. Key Segment for Channeling Investments

9.3.1. By Technology

10. Global Veterinary Diagnostic Market Analysis and Forecasts, 2019 – 2027

10.1. Overview

10.2. Global Veterinary Diagnostic Market Revenue (US$ Mn) and Forecasts, By Species

10.2.1. Companion animals (Definition, Market Penetration (2018), Market Estimation (2013 – 2018), Market Forecast (2019 – 2027), Compound Annual Growth Rate (CAGR), Regional Bifurcation (North America, Europe, Asia Pacific, Middle East and Africa, Latin America) and Information on Cat, Dogs, Others)

10.2.1.1.  Cat

10.2.1.2.  Dogs

10.2.1.3.  Others

10.2.2. Farm animals (Definition, Market Penetration (2018), Market Estimation (2013 – 2018), Market Forecast (2019 – 2027), Compound Annual Growth Rate (CAGR), Regional Bifurcation (North America, Europe, Asia Pacific, Middle East and Africa, Latin America) and Information on Cattle, Swine, Poultry, Horse, Others)

10.2.2.1.  Cattle

10.2.2.2.  Swine

10.2.2.3.  Poultry

10.2.2.4.  Horse

10.2.2.5.  Others

10.3. Key Segment for Channeling Investments

10.3.1. By Species

11. North America Veterinary Diagnostic Market Analysis and Forecasts, 2019 - 2027

11.1. Overview

11.1.1. North America Veterinary Diagnostic Market Revenue (US$ Mn)

11.2. North America Veterinary Diagnostic Market Revenue (US$ Mn) and Forecasts, By Product

11.2.1. Instruments

11.2.2. Consumables

11.3. North America Veterinary Diagnostic Market Revenue (US$ Mn) and Forecasts, By Technology

11.3.1. Immunodiagnostic

11.3.1.1.  Lateral flow assays

11.3.1.2.  ELISA

11.3.1.3.  Immunoassay analyzers

11.3.1.4.  Others

11.3.2. Molecular Diagnostic

11.3.2.1.  Polymerase Chain Reaction (PCR)

11.3.2.2.  Microarrays

11.3.2.3.  Others

11.3.3. Hematology

11.3.3.1.  Cartridges

11.3.3.2.  Analyzers

11.3.4. Clinical Chemistry

11.3.4.1.  Clinical Chemistry Analyzers

11.3.4.2.  Glucose monitoring

11.3.4.3.  Blood gas and electrolyte analysis

11.3.5. Others

11.4. North America Veterinary Diagnostic Market Revenue (US$ Mn) and Forecasts, By Species

11.4.1. Companion animals

11.4.1.1.  Cat

11.4.1.2.  Dogs

11.4.1.3.  Others

11.4.2. Farm animals

11.4.2.1.  Cattle

11.4.2.2.  Swine

11.4.2.3.  Poultry

11.4.2.4.  Horse

11.4.2.5.  Others

11.5. North America Veterinary Diagnostic Market Revenue (US$ Mn) and Forecasts, By Country

11.5.1. U.S

11.5.1.1.  U.S Veterinary Diagnostic Market Revenue (US$ Mn) and Forecasts, By Product

11.5.1.1.1.  Instruments

11.5.1.1.2.  Consumables

11.5.1.2.  U.S Veterinary Diagnostic Market Revenue (US$ Mn) and Forecasts, By Technology

11.5.1.2.1.  Immunodiagnostic

11.5.1.2.1.1. Lateral flow assays

11.5.1.2.1.2. ELISA

11.5.1.2.1.3. Immunoassay analyzers

11.5.1.2.1.4. Others

11.5.1.2.2.  Molecular Diagnostic

11.5.1.2.2.1. Polymerase Chain Reaction (PCR)

11.5.1.2.2.2. Microarrays

11.5.1.2.2.3. Others

11.5.1.2.3.  Hematology

11.5.1.2.3.1. Cartridges

11.5.1.2.3.2. Analyzers

11.5.1.2.4.  Clinical Chemistry

11.5.1.2.4.1. Clinical Chemistry Analyzers

11.5.1.2.4.2. Glucose monitoring

11.5.1.2.4.3. Blood gas and electrolyte analysis

11.5.1.2.5.  Others

11.5.1.3.  U.S Veterinary Diagnostic Market Revenue (US$ Mn) and Forecasts, By Species

11.5.1.3.1.  Companion animals

11.5.1.3.1.1. Cat

11.5.1.3.1.2. Dogs

11.5.1.3.1.3. Others

11.5.1.3.2.  Farm animals

11.5.1.3.2.1. Cattle

11.5.1.3.2.2. Swine

11.5.1.3.2.3. Poultry

11.5.1.3.2.4. Horse

11.5.1.3.2.5. Others

11.5.2. Canada

11.5.2.1.  Canada Veterinary Diagnostic Market Revenue (US$ Mn) and Forecasts, By Product

11.5.2.1.1.  Instruments

11.5.2.1.2.  Consumables

11.5.2.2.  Canada Veterinary Diagnostic Market Revenue (US$ Mn) and Forecasts, By Technology

11.5.2.2.1.  Immunodiagnostic

11.5.2.2.1.1. Lateral flow assays

11.5.2.2.1.2. ELISA

11.5.2.2.1.3. Immunoassay analyzers

11.5.2.2.1.4. Others

11.5.2.2.2.  Molecular Diagnostic

11.5.2.2.2.1. Polymerase Chain Reaction (PCR)

11.5.2.2.2.2. Microarrays

11.5.2.2.2.3. Others

11.5.2.2.3.  Hematology

11.5.2.2.3.1. Cartridges

11.5.2.2.3.2. Analyzers

11.5.2.2.4.  Clinical Chemistry

11.5.2.2.4.1. Clinical Chemistry Analyzers

11.5.2.2.4.2. Glucose monitoring

11.5.2.2.4.3. Blood gas and electrolyte analysis

11.5.2.2.5.  Others

11.5.2.3.  Canada Veterinary Diagnostic Market Revenue (US$ Mn) and Forecasts, By Species

11.5.2.3.1.  Companion animals

11.5.2.3.1.1. Cat

11.5.2.3.1.2. Dogs

11.5.2.3.1.3. Others

11.5.2.3.2.  Farm animals

11.5.2.3.2.1. Cattle

11.5.2.3.2.2. Swine

11.5.2.3.2.3. Poultry

11.5.2.3.2.4. Horse

11.5.2.3.2.5. Others

11.5.3. Mexico

11.5.3.1.  Mexico Veterinary Diagnostic Market Revenue (US$ Mn) and Forecasts, By Product

11.5.3.1.1.  Instruments

11.5.3.1.2.  Consumables

11.5.3.2.  Mexico Veterinary Diagnostic Market Revenue (US$ Mn) and Forecasts, By Technology

11.5.3.2.1.  Immunodiagnostic

11.5.3.2.1.1. Lateral flow assays

11.5.3.2.1.2. ELISA

11.5.3.2.1.3. Immunoassay analyzers

11.5.3.2.1.4. Others

11.5.3.2.2.  Molecular Diagnostic

11.5.3.2.2.1. Polymerase Chain Reaction (PCR)

11.5.3.2.2.2. Microarrays

11.5.3.2.2.3. Others

11.5.3.2.3.  Hematology

11.5.3.2.3.1. Cartridges

11.5.3.2.3.2. Analyzers

11.5.3.2.4.  Clinical Chemistry

11.5.3.2.4.1. Clinical Chemistry Analyzers

11.5.3.2.4.2. Glucose monitoring

11.5.3.2.4.3. Blood gas and electrolyte analysis

11.5.3.2.5.  Others

11.5.3.3.  Mexico Veterinary Diagnostic Market Revenue (US$ Mn) and Forecasts, By Species

11.5.3.3.1.  Companion animals

11.5.3.3.1.1. Cat

11.5.3.3.1.2. Dogs

11.5.3.3.1.3. Others

11.5.3.3.2.  Farm animals

11.5.3.3.2.1. Cattle

11.5.3.3.2.2. Swine

11.5.3.3.2.3. Poultry

11.5.3.3.2.4. Horse

11.5.3.3.2.5. Others

11.5.4. Rest of North America

11.5.4.1.  Rest of North America Veterinary Diagnostic Market Revenue (US$ Mn) and Forecasts, By Product

11.5.4.1.1.  Instruments

11.5.4.1.2.  Consumables

11.5.4.2.  Rest of North America Veterinary Diagnostic Market Revenue (US$ Mn) and Forecasts, By Technology

11.5.4.2.1.  Immunodiagnostic

11.5.4.2.1.1. Lateral flow assays

11.5.4.2.1.2. ELISA

11.5.4.2.1.3. Immunoassay analyzers

11.5.4.2.1.4. Others

11.5.4.2.2.  Molecular Diagnostic

11.5.4.2.2.1. Polymerase Chain Reaction (PCR)

11.5.4.2.2.2. Microarrays

11.5.4.2.2.3. Others

11.5.4.2.3.  Hematology

11.5.4.2.3.1. Cartridges

11.5.4.2.3.2. Analyzers

11.5.4.2.4.  Clinical Chemistry

11.5.4.2.4.1. Clinical Chemistry Analyzers

11.5.4.2.4.2. Glucose monitoring

11.5.4.2.4.3. Blood gas and electrolyte analysis

11.5.4.2.5.  Others

11.5.4.3.  Rest of North America Veterinary Diagnostic Market Revenue (US$ Mn) and Forecasts, By Species

11.5.4.3.1.  Companion animals

11.5.4.3.1.1. Cat

11.5.4.3.1.2. Dogs

11.5.4.3.1.3. Others

11.5.4.3.2.  Farm animals

11.5.4.3.2.1. Cattle

11.5.4.3.2.2. Swine

11.5.4.3.2.3. Poultry

11.5.4.3.2.4. Horse

11.5.4.3.2.5. Others

11.6. Key Segment for Channeling Investments

11.6.1. By Country

11.6.2. By Product

11.6.3. By Technology

11.6.4. By Species

12. Europe Veterinary Diagnostic Market Analysis and Forecasts, 2019 - 2027

12.1. Overview

12.1.1. Europe Veterinary Diagnostic Market Revenue (US$ Mn)

12.2. Europe Veterinary Diagnostic Market Revenue (US$ Mn) and Forecasts, By Product

12.2.1. Instruments

12.2.2. Consumables

12.3. Europe Veterinary Diagnostic Market Revenue (US$ Mn) and Forecasts, By Technology

12.3.1. Immunodiagnostic

12.3.1.1.  Lateral flow assays

12.3.1.2.  ELISA

12.3.1.3.  Immunoassay analyzers

12.3.1.4.  Others

12.3.2. Molecular Diagnostic

12.3.2.1.  Polymerase Chain Reaction (PCR)

12.3.2.2.  Microarrays

12.3.2.3.  Others

12.3.3. Hematology

12.3.3.1.  Cartridges

12.3.3.2.  Analyzers

12.3.4. Clinical Chemistry

12.3.4.1.  Clinical Chemistry Analyzers

12.3.4.2.  Glucose monitoring

12.3.4.3.  Blood gas and electrolyte analysis

12.3.5. Others

12.4. Europe Veterinary Diagnostic Market Revenue (US$ Mn) and Forecasts, By Species

12.4.1. Companion animals

12.4.1.1.  Cat

12.4.1.2.  Dogs

12.4.1.3.  Others

12.4.2. Farm animals

12.4.2.1.  Cattle

12.4.2.2.  Swine

12.4.2.3.  Poultry

12.4.2.4.  Horse

12.4.2.5.  Others

12.5. Europe Veterinary Diagnostic Market Revenue (US$ Mn) and Forecasts, By Country

12.5.1. France

12.5.1.1.  France Veterinary Diagnostic Market Revenue (US$ Mn) and Forecasts, By Product

12.5.1.1.1.  Instruments

12.5.1.1.2.  Consumables

12.5.1.2.  France Veterinary Diagnostic Market Revenue (US$ Mn) and Forecasts, By Technology

12.5.1.2.1.  Immunodiagnostic

12.5.1.2.1.1. Lateral flow assays

12.5.1.2.1.2. ELISA

12.5.1.2.1.3. Immunoassay analyzers

12.5.1.2.1.4. Others

12.5.1.2.2.  Molecular Diagnostic

12.5.1.2.2.1. Polymerase Chain Reaction (PCR)

12.5.1.2.2.2. Microarrays

12.5.1.2.2.3. Others

12.5.1.2.3.  Hematology

12.5.1.2.3.1. Cartridges

12.5.1.2.3.2. Analyzers

12.5.1.2.4.  Clinical Chemistry

12.5.1.2.4.1. Clinical Chemistry Analyzers

12.5.1.2.4.2. Glucose monitoring

12.5.1.2.4.3. Blood gas and electrolyte analysis

12.5.1.2.5.  Others

12.5.1.3.  France Veterinary Diagnostic Market Revenue (US$ Mn) and Forecasts, By Species

12.5.1.3.1.  Companion animals

12.5.1.3.1.1. Cat

12.5.1.3.1.2. Dogs

12.5.1.3.1.3. Others

12.5.1.3.2.  Farm animals

12.5.1.3.2.1. Cattle

12.5.1.3.2.2. Swine

12.5.1.3.2.3. Poultry

12.5.1.3.2.4. Horse

12.5.1.3.2.5. Others

12.5.2. The UK

12.5.2.1.  The UK Veterinary Diagnostic Market Revenue (US$ Mn) and Forecasts, By Product

12.5.2.1.1.  Instruments

12.5.2.1.2.  Consumables

12.5.2.2.  The UK Veterinary Diagnostic Market Revenue (US$ Mn) and Forecasts, By Technology

12.5.2.2.1.  Immunodiagnostic

12.5.2.2.1.1. Lateral flow assays

12.5.2.2.1.2. ELISA

12.5.2.2.1.3. Immunoassay analyzers

12.5.2.2.1.4. Others

12.5.2.2.2.  Molecular Diagnostic

12.5.2.2.2.1. Polymerase Chain Reaction (PCR)

12.5.2.2.2.2. Microarrays

12.5.2.2.2.3. Others

12.5.2.2.3.  Hematology

12.5.2.2.3.1. Cartridges

12.5.2.2.3.2. Analyzers

12.5.2.2.4.  Clinical Chemistry

12.5.2.2.4.1. Clinical Chemistry Analyzers

12.5.2.2.4.2. Glucose monitoring

12.5.2.2.4.3. Blood gas and electrolyte analysis

12.5.2.2.5.  Others

12.5.2.3.  The UK Veterinary Diagnostic Market Revenue (US$ Mn) and Forecasts, By Species

12.5.2.3.1.  Companion animals

12.5.2.3.1.1. Cat

12.5.2.3.1.2. Dogs

12.5.2.3.1.3. Others

12.5.2.3.2.  Farm animals

12.5.2.3.2.1. Cattle

12.5.2.3.2.2. Swine

12.5.2.3.2.3. Poultry

12.5.2.3.2.4. Horse

12.5.2.3.2.5. Others

12.5.3. Spain

12.5.3.1.  Spain Veterinary Diagnostic Market Revenue (US$ Mn) and Forecasts, By Product

12.5.3.1.1.  Instruments

12.5.3.1.2.  Consumables

12.5.3.2.  Spain Veterinary Diagnostic Market Revenue (US$ Mn) and Forecasts, By Technology

12.5.3.2.1.  Immunodiagnostic

12.5.3.2.1.1. Lateral flow assays

12.5.3.2.1.2. ELISA

12.5.3.2.1.3. Immunoassay analyzers

12.5.3.2.1.4. Others

12.5.3.2.2.  Molecular Diagnostic

12.5.3.2.2.1. Polymerase Chain Reaction (PCR)

12.5.3.2.2.2. Microarrays

12.5.3.2.2.3. Others

12.5.3.2.3.  Hematology

12.5.3.2.3.1. Cartridges

12.5.3.2.3.2. Analyzers

12.5.3.2.4.  Clinical Chemistry

12.5.3.2.4.1. Clinical Chemistry Analyzers

12.5.3.2.4.2. Glucose monitoring

12.5.3.2.4.3. Blood gas and electrolyte analysis

12.5.3.2.5.  Others

12.5.3.3.  Spain Veterinary Diagnostic Market Revenue (US$ Mn) and Forecasts, By Species

12.5.3.3.1.  Companion animals

12.5.3.3.1.1. Cat

12.5.3.3.1.2. Dogs

12.5.3.3.1.3. Others

12.5.3.3.2.  Farm animals

12.5.3.3.2.1. Cattle

12.5.3.3.2.2. Swine

12.5.3.3.2.3. Poultry

12.5.3.3.2.4. Horse

12.5.3.3.2.5. Others

12.5.4. Germany

12.5.4.1.  Germany Veterinary Diagnostic Market Revenue (US$ Mn) and Forecasts, By Product

12.5.4.1.1.  Instruments

12.5.4.1.2.  Consumables

12.5.4.2.  Germany Veterinary Diagnostic Market Revenue (US$ Mn) and Forecasts, By Technology

12.5.4.2.1.  Immunodiagnostic

12.5.4.2.1.1. Lateral flow assays

12.5.4.2.1.2. ELISA

12.5.4.2.1.3. Immunoassay analyzers

12.5.4.2.1.4. Others

12.5.4.2.2.  Molecular Diagnostic

12.5.4.2.2.1. Polymerase Chain Reaction (PCR)

12.5.4.2.2.2. Microarrays

12.5.4.2.2.3. Others

12.5.4.2.3.  Hematology

12.5.4.2.3.1. Cartridges

12.5.4.2.3.2. Analyzers

12.5.4.2.4.  Clinical Chemistry

12.5.4.2.4.1. Clinical Chemistry Analyzers

12.5.4.2.4.2. Glucose monitoring

12.5.4.2.4.3. Blood gas and electrolyte analysis

12.5.4.2.5.  Others

12.5.4.3.  Germany Veterinary Diagnostic Market Revenue (US$ Mn) and Forecasts, By Species

12.5.4.3.1.  Companion animals

12.5.4.3.1.1. Cat

12.5.4.3.1.2. Dogs

12.5.4.3.1.3. Others

12.5.4.3.2.  Farm animals

12.5.4.3.2.1. Cattle

12.5.4.3.2.2. Swine

12.5.4.3.2.3. Poultry

12.5.4.3.2.4. Horse

12.5.4.3.2.5. Others

12.5.5. Italy

12.5.5.1.  Italy Veterinary Diagnostic Market Revenue (US$ Mn) and Forecasts, By Product

12.5.5.1.1.  Instruments

12.5.5.1.2.  Consumables

12.5.5.2.  Italy Veterinary Diagnostic Market Revenue (US$ Mn) and Forecasts, By Technology

12.5.5.2.1.  Immunodiagnostic

12.5.5.2.1.1. Lateral flow assays

12.5.5.2.1.2. ELISA

12.5.5.2.1.3. Immunoassay analyzers

12.5.5.2.1.4. Others

12.5.5.2.2.  Molecular Diagnostic

12.5.5.2.2.1. Polymerase Chain Reaction (PCR)

12.5.5.2.2.2. Microarrays

12.5.5.2.2.3. Others

12.5.5.2.3.  Hematology

12.5.5.2.3.1. Cartridges

12.5.5.2.3.2. Analyzers

12.5.5.2.4.  Clinical Chemistry

12.5.5.2.4.1. Clinical Chemistry Analyzers

12.5.5.2.4.2. Glucose monitoring

12.5.5.2.4.3. Blood gas and electrolyte analysis

12.5.5.2.5.  Others

12.5.5.3.  Italy Veterinary Diagnostic Market Revenue (US$ Mn) and Forecasts, By Species

12.5.5.3.1.  Companion animals

12.5.5.3.1.1. Cat

12.5.5.3.1.2. Dogs

12.5.5.3.1.3. Others

12.5.5.3.2.  Farm animals

12.5.5.3.2.1. Cattle

12.5.5.3.2.2. Swine

12.5.5.3.2.3. Poultry

12.5.5.3.2.4. Horse

12.5.5.3.2.5. Others

12.5.6. Nordic Countries

12.5.6.1.  Nordic Countries Veterinary Diagnostic Market Revenue (US$ Mn) and Forecasts, By Product

12.5.6.1.1.  Instruments

12.5.6.1.2.  Consumables

12.5.6.2.  Nordic Countries Veterinary Diagnostic Market Revenue (US$ Mn) and Forecasts, By Technology

12.5.6.2.1.  Immunodiagnostic

12.5.6.2.1.1. Lateral flow assays

12.5.6.2.1.2. ELISA

12.5.6.2.1.3. Immunoassay analyzers

12.5.6.2.1.4. Others

12.5.6.2.2.  Molecular Diagnostic

12.5.6.2.2.1. Polymerase Chain Reaction (PCR)

12.5.6.2.2.2. Microarrays

12.5.6.2.2.3. Others

12.5.6.2.3.  Hematology

12.5.6.2.3.1. Cartridges

12.5.6.2.3.2. Analyzers

12.5.6.2.4.  Clinical Chemistry

12.5.6.2.4.1. Clinical Chemistry Analyzers

12.5.6.2.4.2. Glucose monitoring

12.5.6.2.4.3. Blood gas and electrolyte analysis

12.5.6.2.5.  Others

12.5.6.3.  Nordic Countries Veterinary Diagnostic Market Revenue (US$ Mn) and Forecasts, By Species

12.5.6.3.1.  Companion animals

12.5.6.3.1.1. Cat

12.5.6.3.1.2. Dogs

12.5.6.3.1.3. Others

12.5.6.3.2.  Farm animals

12.5.6.3.2.1. Cattle

12.5.6.3.2.2. Swine

12.5.6.3.2.3. Poultry

12.5.6.3.2.4. Horse

12.5.6.3.2.5. Others

12.5.6.4.  Nordic Countries Veterinary Diagnostic Market Revenue (US$ Mn) and Forecasts, By Country

12.5.6.4.1.  Denmark

12.5.6.4.2.  Finland

12.5.6.4.3.  Iceland

12.5.6.4.4.  Sweden

12.5.6.4.5.  Norway

12.5.7. Benelux Union

12.5.7.1.  Benelux Union Veterinary Diagnostic Market Revenue (US$ Mn) and Forecasts, By Product

12.5.7.1.1.  Instruments

12.5.7.1.2.  Consumables

12.5.7.2.  Benelux Union Veterinary Diagnostic Market Revenue (US$ Mn) and Forecasts, By Technology

12.5.7.2.1.  Immunodiagnostic

12.5.7.2.1.1. Lateral flow assays

12.5.7.2.1.2. ELISA

12.5.7.2.1.3. Immunoassay analyzers

12.5.7.2.1.4. Others

12.5.7.2.2.  Molecular Diagnostic

12.5.7.2.2.1. Polymerase Chain Reaction (PCR)

12.5.7.2.2.2. Microarrays

12.5.7.2.2.3. Others

12.5.7.2.3.  Hematology

12.5.7.2.3.1. Cartridges

12.5.7.2.3.2. Analyzers

12.5.7.2.4.  Clinical Chemistry

12.5.7.2.4.1. Clinical Chemistry Analyzers

12.5.7.2.4.2. Glucose monitoring

12.5.7.2.4.3. Blood gas and electrolyte analysis

12.5.7.2.5.  Others

12.5.7.3.  Benelux Union Veterinary Diagnostic Market Revenue (US$ Mn) and Forecasts, By Species

12.5.7.3.1.  Companion animals

12.5.7.3.1.1. Cat

12.5.7.3.1.2. Dogs

12.5.7.3.1.3. Others

12.5.7.3.2.  Farm animals

12.5.7.3.2.1. Cattle

12.5.7.3.2.2. Swine

12.5.7.3.2.3. Poultry

12.5.7.3.2.4. Horse

12.5.7.3.2.5. Others

12.5.7.4.  Benelux Union Veterinary Diagnostic Market Revenue (US$ Mn) and Forecasts, By Country

12.5.7.4.1.  Belgium

12.5.7.4.2.  The Netherlands

12.5.7.4.3.  Luxembourg

12.5.8. Rest of Europe

12.5.8.1.  Rest of Europe Veterinary Diagnostic Market Revenue (US$ Mn) and Forecasts, By Product

12.5.8.1.1.  Instruments

12.5.8.1.2.  Consumables

12.5.8.2.  Rest of Europe Veterinary Diagnostic Market Revenue (US$ Mn) and Forecasts, By Technology

12.5.8.2.1.  Immunodiagnostic

12.5.8.2.1.1. Lateral flow assays

12.5.8.2.1.2. ELISA

12.5.8.2.1.3. Immunoassay analyzers

12.5.8.2.1.4. Others

12.5.8.2.2.  Molecular Diagnostic

12.5.8.2.2.1. Polymerase Chain Reaction (PCR)

12.5.8.2.2.2. Microarrays

12.5.8.2.2.3. Others

12.5.8.2.3.  Hematology

12.5.8.2.3.1. Cartridges

12.5.8.2.3.2. Analyzers

12.5.8.2.4.  Clinical Chemistry

12.5.8.2.4.1. Clinical Chemistry Analyzers

12.5.8.2.4.2. Glucose monitoring

12.5.8.2.4.3. Blood gas and electrolyte analysis

12.5.8.2.5.  Others

12.5.8.3.  Rest of Europe Veterinary Diagnostic Market Revenue (US$ Mn) and Forecasts, By Species

12.5.8.3.1.  Companion animals

12.5.8.3.1.1. Cat

12.5.8.3.1.2. Dogs

12.5.8.3.1.3. Others

12.5.8.3.2.  Farm animals

12.5.8.3.2.1. Cattle

12.5.8.3.2.2. Swine

12.5.8.3.2.3. Poultry

12.5.8.3.2.4. Horse

12.5.8.3.2.5. Others

12.6. Key Segment for Channeling Investments

12.6.1. By Country

12.6.2. By Product

12.6.3. By Technology

12.6.4. By Species

13. Asia Pacific Veterinary Diagnostic Market Analysis and Forecasts, 2019 - 2027

13.1. Overview

13.1.1. Asia Pacific Veterinary Diagnostic Market Revenue (US$ Mn)

13.2. Asia Pacific Veterinary Diagnostic Market Revenue (US$ Mn) and Forecasts, By Product

13.2.1. Instruments

13.2.2. Consumables

13.3. Asia Pacific Veterinary Diagnostic Market Revenue (US$ Mn) and Forecasts, By Technology

13.3.1. Immunodiagnostic

13.3.1.1.  Lateral flow assays

13.3.1.2.  ELISA

13.3.1.3.  Immunoassay analyzers

13.3.1.4.  Others

13.3.2. Molecular Diagnostic

13.3.2.1.  Polymerase Chain Reaction (PCR)

13.3.2.2.  Microarrays

13.3.2.3.  Others

13.3.3. Hematology

13.3.3.1.  Cartridges

13.3.3.2.  Analyzers

13.3.4. Clinical Chemistry

13.3.4.1.  Clinical Chemistry Analyzers

13.3.4.2.  Glucose monitoring

13.3.4.3.  Blood gas and electrolyte analysis

13.3.5. Others

13.4. Asia Pacific Veterinary Diagnostic Market Revenue (US$ Mn) and Forecasts, By Species

13.4.1. Companion animals

13.4.1.1.  Cat

13.4.1.2.  Dogs

13.4.1.3.  Others

13.4.2. Farm animals

13.4.2.1.  Cattle

13.4.2.2.  Swine

13.4.2.3.  Poultry

13.4.2.4.  Horse

13.4.2.5.  Others

13.5. Asia Pacific Veterinary Diagnostic Market Revenue (US$ Mn) and Forecasts, By Country

13.5.1. China

13.5.1.1.  China Veterinary Diagnostic Market Revenue (US$ Mn) and Forecasts, By Product

13.5.1.1.1.  Instruments

13.5.1.1.2.  Consumables

13.5.1.2.  China Veterinary Diagnostic Market Revenue (US$ Mn) and Forecasts, By Technology

13.5.1.2.1.  Immunodiagnostic

13.5.1.2.1.1. Lateral flow assays

13.5.1.2.1.2. ELISA

13.5.1.2.1.3. Immunoassay analyzers

13.5.1.2.1.4. Others

13.5.1.2.2.  Molecular Diagnostic

13.5.1.2.2.1. Polymerase Chain Reaction (PCR)

13.5.1.2.2.2. Microarrays

13.5.1.2.2.3. Others

13.5.1.2.3.  Hematology

13.5.1.2.3.1. Cartridges

13.5.1.2.3.2. Analyzers

13.5.1.2.4.  Clinical Chemistry

13.5.1.2.4.1. Clinical Chemistry Analyzers

13.5.1.2.4.2. Glucose monitoring

13.5.1.2.4.3. Blood gas and electrolyte analysis

13.5.1.2.5.  Others

13.5.1.3.  China Veterinary Diagnostic Market Revenue (US$ Mn) and Forecasts, By Species

13.5.1.3.1.  Companion animals

13.5.1.3.1.1. Cat

13.5.1.3.1.2. Dogs

13.5.1.3.1.3. Others

13.5.1.3.2.  Farm animals

13.5.1.3.2.1. Cattle

13.5.1.3.2.2. Swine

13.5.1.3.2.3. Poultry

13.5.1.3.2.4. Horse

13.5.1.3.2.5. Others

13.5.2. Japan

13.5.2.1.  Japan Veterinary Diagnostic Market Revenue (US$ Mn) and Forecasts, By Product

13.5.2.1.1.  Instruments

13.5.2.1.2.  Consumables

13.5.2.2.  Japan Veterinary Diagnostic Market Revenue (US$ Mn) and Forecasts, By Technology

13.5.2.2.1.  Immunodiagnostic

13.5.2.2.1.1. Lateral flow assays

13.5.2.2.1.2. ELISA

13.5.2.2.1.3. Immunoassay analyzers

13.5.2.2.1.4. Others

13.5.2.2.2.  Molecular Diagnostic

13.5.2.2.2.1. Polymerase Chain Reaction (PCR)

13.5.2.2.2.2. Microarrays

13.5.2.2.2.3. Others

13.5.2.2.3.  Hematology

13.5.2.2.3.1. Cartridges

13.5.2.2.3.2. Analyzers

13.5.2.2.4.  Clinical Chemistry

13.5.2.2.4.1. Clinical Chemistry Analyzers

13.5.2.2.4.2. Glucose monitoring

13.5.2.2.4.3. Blood gas and electrolyte analysis

13.5.2.2.5.  Others

13.5.2.3.  Japan Veterinary Diagnostic Market Revenue (US$ Mn) and Forecasts, By Species

13.5.2.3.1.  Companion animals

13.5.2.3.1.1. Cat

13.5.2.3.1.2. Dogs

13.5.2.3.1.3. Others

13.5.2.3.2.  Farm animals

13.5.2.3.2.1. Cattle

13.5.2.3.2.2. Swine

13.5.2.3.2.3. Poultry

13.5.2.3.2.4. Horse

13.5.2.3.2.5. Others

13.5.3. India

13.5.3.1.  India Veterinary Diagnostic Market Revenue (US$ Mn) and Forecasts, By Product

13.5.3.1.1.  Instruments

13.5.3.1.2.  Consumables

13.5.3.2.  India Veterinary Diagnostic Market Revenue (US$ Mn) and Forecasts, By Technology

13.5.3.2.1.  Immunodiagnostic

13.5.3.2.1.1. Lateral flow assays

13.5.3.2.1.2. ELISA

13.5.3.2.1.3. Immunoassay analyzers

13.5.3.2.1.4. Others

13.5.3.2.2.  Molecular Diagnostic

13.5.3.2.2.1. Polymerase Chain Reaction (PCR)

13.5.3.2.2.2. Microarrays

13.5.3.2.2.3. Others

13.5.3.2.3.  Hematology

13.5.3.2.3.1. Cartridges

13.5.3.2.3.2. Analyzers

13.5.3.2.4.  Clinical Chemistry

13.5.3.2.4.1. Clinical Chemistry Analyzers

13.5.3.2.4.2. Glucose monitoring

13.5.3.2.4.3. Blood gas and electrolyte analysis

13.5.3.2.5.  Others

13.5.3.3.  India Veterinary Diagnostic Market Revenue (US$ Mn) and Forecasts, By Species

13.5.3.3.1.  Companion animals

13.5.3.3.1.1. Cat

13.5.3.3.1.2. Dogs

13.5.3.3.1.3. Others

13.5.3.3.2.  Farm animals

13.5.3.3.2.1. Cattle

13.5.3.3.2.2. Swine

13.5.3.3.2.3. Poultry

13.5.3.3.2.4. Horse

13.5.3.3.2.5. Others

13.5.4. New Zealand

13.5.4.1.  New Zealand Veterinary Diagnostic Market Revenue (US$ Mn) and Forecasts, By Product

13.5.4.1.1.  Instruments

13.5.4.1.2.  Consumables

13.5.4.2.  New Zealand Veterinary Diagnostic Market Revenue (US$ Mn) and Forecasts, By Technology

13.5.4.2.1.  Immunodiagnostic

13.5.4.2.1.1. Lateral flow assays

13.5.4.2.1.2. ELISA

13.5.4.2.1.3. Immunoassay analyzers

13.5.4.2.1.4. Others

13.5.4.2.2.  Molecular Diagnostic

13.5.4.2.2.1. Polymerase Chain Reaction (PCR)

13.5.4.2.2.2. Microarrays

13.5.4.2.2.3. Others

13.5.4.2.3.  Hematology

13.5.4.2.3.1. Cartridges

13.5.4.2.3.2. Analyzers

13.5.4.2.4.  Clinical Chemistry

13.5.4.2.4.1. Clinical Chemistry Analyzers

13.5.4.2.4.2. Glucose monitoring

13.5.4.2.4.3. Blood gas and electrolyte analysis

13.5.4.2.5.  Others

13.5.4.3.  New Zealand Veterinary Diagnostic Market Revenue (US$ Mn) and Forecasts, By Species

13.5.4.3.1.  Companion animals

13.5.4.3.1.1. Cat

13.5.4.3.1.2. Dogs

13.5.4.3.1.3. Others

13.5.4.3.2.  Farm animals

13.5.4.3.2.1. Cattle

13.5.4.3.2.2. Swine

13.5.4.3.2.3. Poultry

13.5.4.3.2.4. Horse

13.5.4.3.2.5. Others

13.5.5. Australia

13.5.5.1.  Australia Veterinary Diagnostic Market Revenue (US$ Mn) and Forecasts, By Product

13.5.5.1.1.  Instruments

13.5.5.1.2.  Consumables

13.5.5.2.  Australia Veterinary Diagnostic Market Revenue (US$ Mn) and Forecasts, By Technology

13.5.5.2.1.  Immunodiagnostic

13.5.5.2.1.1. Lateral flow assays

13.5.5.2.1.2. ELISA

13.5.5.2.1.3. Immunoassay analyzers

13.5.5.2.1.4. Others

13.5.5.2.2.  Molecular Diagnostic

13.5.5.2.2.1. Polymerase Chain Reaction (PCR)

13.5.5.2.2.2. Microarrays

13.5.5.2.2.3. Others

13.5.5.2.3.  Hematology

13.5.5.2.3.1. Cartridges

13.5.5.2.3.2. Analyzers

13.5.5.2.4.  Clinical Chemistry

13.5.5.2.4.1. Clinical Chemistry Analyzers

13.5.5.2.4.2. Glucose monitoring

13.5.5.2.4.3. Blood gas and electrolyte analysis

13.5.5.2.5.  Others

13.5.5.3.  Australia Veterinary Diagnostic Market Revenue (US$ Mn) and Forecasts, By Species

13.5.5.3.1.  Companion animals

13.5.5.3.1.1. Cat

13.5.5.3.1.2. Dogs

13.5.5.3.1.3. Others

13.5.5.3.2.  Farm animals

13.5.5.3.2.1. Cattle

13.5.5.3.2.2. Swine

13.5.5.3.2.3. Poultry

13.5.5.3.2.4. Horse

13.5.5.3.2.5. Others

13.5.6. South Korea

13.5.6.1.  South Korea Veterinary Diagnostic Market Revenue (US$ Mn) and Forecasts, By Product

13.5.6.1.1.  Instruments

13.5.6.1.2.  Consumables

13.5.6.2.  South Korea Veterinary Diagnostic Market Revenue (US$ Mn) and Forecasts, By Technology

13.5.6.2.1.  Immunodiagnostic

13.5.6.2.1.1. Lateral flow assays

13.5.6.2.1.2. ELISA

13.5.6.2.1.3. Immunoassay analyzers

13.5.6.2.1.4. Others

13.5.6.2.2.  Molecular Diagnostic

13.5.6.2.2.1. Polymerase Chain Reaction (PCR)

13.5.6.2.2.2. Microarrays

13.5.6.2.2.3. Others

13.5.6.2.3.  Hematology

13.5.6.2.3.1. Cartridges

13.5.6.2.3.2. Analyzers

13.5.6.2.4.  Clinical Chemistry

13.5.6.2.4.1. Clinical Chemistry Analyzers

13.5.6.2.4.2. Glucose monitoring

13.5.6.2.4.3. Blood gas and electrolyte analysis

13.5.6.2.5.  Others

13.5.6.3.  South Korea Veterinary Diagnostic Market Revenue (US$ Mn) and Forecasts, By Species

13.5.6.3.1.  Companion animals

13.5.6.3.1.1. Cat

13.5.6.3.1.2. Dogs

13.5.6.3.1.3. Others

13.5.6.3.2.  Farm animals

13.5.6.3.2.1. Cattle

13.5.6.3.2.2. Swine

13.5.6.3.2.3. Poultry

13.5.6.3.2.4. Horse

13.5.6.3.2.5. Others

13.5.7. Southeast Asia

13.5.7.1.  Southeast Asia Veterinary Diagnostic Market Revenue (US$ Mn) and Forecasts, By Product

13.5.7.1.1.  Instruments

13.5.7.1.2.  Consumables

13.5.7.2.  Southeast Asia Veterinary Diagnostic Market Revenue (US$ Mn) and Forecasts, By Technology

13.5.7.2.1.  Immunodiagnostic

13.5.7.2.1.1. Lateral flow assays

13.5.7.2.1.2. ELISA

13.5.7.2.1.3. Immunoassay analyzers

13.5.7.2.1.4. Others

13.5.7.2.2.  Molecular Diagnostic

13.5.7.2.2.1. Polymerase Chain Reaction (PCR)

13.5.7.2.2.2. Microarrays

13.5.7.2.2.3. Others

13.5.7.2.3.  Hematology

13.5.7.2.3.1. Cartridges

13.5.7.2.3.2. Analyzers

13.5.7.2.4.  Clinical Chemistry

13.5.7.2.4.1. Clinical Chemistry Analyzers

13.5.7.2.4.2. Glucose monitoring

13.5.7.2.4.3. Blood gas and electrolyte analysis

13.5.7.2.5.  Others

13.5.7.3.  Southeast Asia Veterinary Diagnostic Market Revenue (US$ Mn) and Forecasts, By Species

13.5.7.3.1.  Companion animals

13.5.7.3.1.1. Cat

13.5.7.3.1.2. Dogs

13.5.7.3.1.3. Others

13.5.7.3.2.  Farm animals

13.5.7.3.2.1. Cattle

13.5.7.3.2.2. Swine

13.5.7.3.2.3. Poultry

13.5.7.3.2.4. Horse

13.5.7.3.2.5. Others

13.5.7.4.  Southeast Asia Veterinary Diagnostic Market Revenue (US$ Mn) and Forecasts, By Country

13.5.7.4.1.  Indonesia

13.5.7.4.2.  Thailand

13.5.7.4.3.  Malaysia

13.5.7.4.4.  Singapore

13.5.7.4.5.  Rest of Southeast Asia

13.5.8. Rest of Asia Pacific

13.5.8.1.  Rest of Asia Pacific Veterinary Diagnostic Market Revenue (US$ Mn) and Forecasts, By Product

13.5.8.1.1.  Instruments

13.5.8.1.2.  Consumables

13.5.8.2.  Rest of Asia Pacific Veterinary Diagnostic Market Revenue (US$ Mn) and Forecasts, By Technology

13.5.8.2.1.  Immunodiagnostic

13.5.8.2.1.1. Lateral flow assays

13.5.8.2.1.2. ELISA

13.5.8.2.1.3. Immunoassay analyzers

13.5.8.2.1.4. Others

13.5.8.2.2.  Molecular Diagnostic

13.5.8.2.2.1. Polymerase Chain Reaction (PCR)

13.5.8.2.2.2. Microarrays

13.5.8.2.2.3. Others

13.5.8.2.3.  Hematology

13.5.8.2.3.1. Cartridges

13.5.8.2.3.2. Analyzers

13.5.8.2.4.  Clinical Chemistry

13.5.8.2.4.1. Clinical Chemistry Analyzers

13.5.8.2.4.2. Glucose monitoring

13.5.8.2.4.3. Blood gas and electrolyte analysis

13.5.8.2.5.  Others

13.5.8.3.  Rest of Asia Pacific Veterinary Diagnostic Market Revenue (US$ Mn) and Forecasts, By Species

13.5.8.3.1.  Companion animals

13.5.8.3.1.1. Cat

13.5.8.3.1.2. Dogs

13.5.8.3.1.3. Others

13.5.8.3.2.  Farm animals

13.5.8.3.2.1. Cattle

13.5.8.3.2.2. Swine

13.5.8.3.2.3. Poultry

13.5.8.3.2.4. Horse

13.5.8.3.2.5. Others

13.6. Key Segment for Channeling Investments

13.6.1. By Country

13.6.2. By Product

13.6.3. By Technology

13.6.4. By Species

14. Middle East and Africa Veterinary Diagnostic Market Analysis and Forecasts, 2019 - 2027

14.1. Overview

14.1.1. Middle East and Africa Veterinary Diagnostic Market Revenue (US$ Mn)

14.2. Middle East and Africa Veterinary Diagnostic Market Revenue (US$ Mn) and Forecasts, By Product

14.2.1. Instruments

14.2.2. Consumables

14.3. Middle East and Africa Veterinary Diagnostic Market Revenue (US$ Mn) and Forecasts, By Technology

14.3.1. Immunodiagnostic

14.3.1.1.  Lateral flow assays

14.3.1.2.  ELISA

14.3.1.3.  Immunoassay analyzers

14.3.1.4.  Others

14.3.2. Molecular Diagnostic

14.3.2.1.  Polymerase Chain Reaction (PCR)

14.3.2.2.  Microarrays

14.3.2.3.  Others

14.3.3. Hematology

14.3.3.1.  Cartridges

14.3.3.2.  Analyzers

14.3.4. Clinical Chemistry

14.3.4.1.  Clinical Chemistry Analyzers

14.3.4.2.  Glucose monitoring

14.3.4.3.  Blood gas and electrolyte analysis

14.3.5. Others

14.4. Middle East and Africa Veterinary Diagnostic Market Revenue (US$ Mn) and Forecasts, By Species

14.4.1. Companion animals

14.4.1.1.  Cat

14.4.1.2.  Dogs

14.4.1.3.  Others

14.4.2. Farm animals

14.4.2.1.  Cattle

14.4.2.2.  Swine

14.4.2.3.  Poultry

14.4.2.4.  Horse

14.4.2.5.  Others

14.5. Middle East and Africa Veterinary Diagnostic Market Revenue (US$ Mn) and Forecasts, By Country

14.5.1. Saudi Arabia

14.5.1.1.  Saudi Arabia Veterinary Diagnostic Market Revenue (US$ Mn) and Forecasts, By Product

14.5.1.1.1.  Instruments

14.5.1.1.2.  Consumables

14.5.1.2.  Saudi Arabia Veterinary Diagnostic Market Revenue (US$ Mn) and Forecasts, By Technology

14.5.1.2.1.  Immunodiagnostic

14.5.1.2.1.1. Lateral flow assays

14.5.1.2.1.2. ELISA

14.5.1.2.1.3. Immunoassay analyzers

14.5.1.2.1.4. Others

14.5.1.2.2.  Molecular Diagnostic

14.5.1.2.2.1. Polymerase Chain Reaction (PCR)

14.5.1.2.2.2. Microarrays

14.5.1.2.2.3. Others

14.5.1.2.3.  Hematology

14.5.1.2.3.1. Cartridges

14.5.1.2.3.2. Analyzers

14.5.1.2.4.  Clinical Chemistry

14.5.1.2.4.1. Clinical Chemistry Analyzers

14.5.1.2.4.2. Glucose monitoring

14.5.1.2.4.3. Blood gas and electrolyte analysis

14.5.1.2.5.  Others

14.5.1.3.  Saudi Arabia Veterinary Diagnostic Market Revenue (US$ Mn) and Forecasts, By Species

14.5.1.3.1.  Companion animals

14.5.1.3.1.1. Cat

14.5.1.3.1.2. Dogs

14.5.1.3.1.3. Others

14.5.1.3.2.  Farm animals

14.5.1.3.2.1. Cattle

14.5.1.3.2.2. Swine

14.5.1.3.2.3. Poultry

14.5.1.3.2.4. Horse

14.5.1.3.2.5. Others

14.5.2. UAE

14.5.2.1.  UAE Veterinary Diagnostic Market Revenue (US$ Mn) and Forecasts, By Product

14.5.2.1.1.  Instruments

14.5.2.1.2.  Consumables

14.5.2.2.  UAE Veterinary Diagnostic Market Revenue (US$ Mn) and Forecasts, By Technology

14.5.2.2.1.  Immunodiagnostic

14.5.2.2.1.1. Lateral flow assays

14.5.2.2.1.2. ELISA

14.5.2.2.1.3. Immunoassay analyzers

14.5.2.2.1.4. Others

14.5.2.2.2.  Molecular Diagnostic

14.5.2.2.2.1. Polymerase Chain Reaction (PCR)

14.5.2.2.2.2. Microarrays

14.5.2.2.2.3. Others

14.5.2.2.3.  Hematology

14.5.2.2.3.1. Cartridges

14.5.2.2.3.2. Analyzers

14.5.2.2.4.  Clinical Chemistry

14.5.2.2.4.1. Clinical Chemistry Analyzers

14.5.2.2.4.2. Glucose monitoring

14.5.2.2.4.3. Blood gas and electrolyte analysis

14.5.2.2.5.  Others

14.5.2.3.  UAE Veterinary Diagnostic Market Revenue (US$ Mn) and Forecasts, By Species

14.5.2.3.1.  Companion animals

14.5.2.3.1.1. Cat

14.5.2.3.1.2. Dogs

14.5.2.3.1.3. Others

14.5.2.3.2.  Farm animals

14.5.2.3.2.1. Cattle

14.5.2.3.2.2. Swine

14.5.2.3.2.3. Poultry

14.5.2.3.2.4. Horse

14.5.2.3.2.5. Others

14.5.3. Egypt

14.5.3.1.  Egypt Veterinary Diagnostic Market Revenue (US$ Mn) and Forecasts, By Product

14.5.3.1.1.  Instruments

14.5.3.1.2.  Consumables

14.5.3.2.  Egypt Veterinary Diagnostic Market Revenue (US$ Mn) and Forecasts, By Technology

14.5.3.2.1.  Immunodiagnostic

14.5.3.2.1.1. Lateral flow assays

14.5.3.2.1.2. ELISA

14.5.3.2.1.3. Immunoassay analyzers

14.5.3.2.1.4. Others

14.5.3.2.2.  Molecular Diagnostic

14.5.3.2.2.1. Polymerase Chain Reaction (PCR)

14.5.3.2.2.2. Microarrays

14.5.3.2.2.3. Others

14.5.3.2.3.  Hematology

14.5.3.2.3.1. Cartridges

14.5.3.2.3.2. Analyzers

14.5.3.2.4.  Clinical Chemistry

14.5.3.2.4.1. Clinical Chemistry Analyzers

14.5.3.2.4.2. Glucose monitoring

14.5.3.2.4.3. Blood gas and electrolyte analysis

14.5.3.2.5.  Others

14.5.3.3.  Egypt Veterinary Diagnostic Market Revenue (US$ Mn) and Forecasts, By Species

14.5.3.3.1.  Companion animals

14.5.3.3.1.1. Cat

14.5.3.3.1.2. Dogs

14.5.3.3.1.3. Others

14.5.3.3.2.  Farm animals

14.5.3.3.2.1. Cattle

14.5.3.3.2.2. Swine

14.5.3.3.2.3. Poultry

14.5.3.3.2.4. Horse

14.5.3.3.2.5. Others

14.5.4. Kuwait

14.5.4.1.  Kuwait Veterinary Diagnostic Market Revenue (US$ Mn) and Forecasts, By Product

14.5.4.1.1.  Instruments

14.5.4.1.2.  Consumables

14.5.4.2.  Kuwait Veterinary Diagnostic Market Revenue (US$ Mn) and Forecasts, By Technology

14.5.4.2.1.  Immunodiagnostic

14.5.4.2.1.1. Lateral flow assays

14.5.4.2.1.2. ELISA

14.5.4.2.1.3. Immunoassay analyzers

14.5.4.2.1.4. Others

14.5.4.2.2.  Molecular Diagnostic

14.5.4.2.2.1. Polymerase Chain Reaction (PCR)

14.5.4.2.2.2. Microarrays

14.5.4.2.2.3. Others

14.5.4.2.3.  Hematology

14.5.4.2.3.1. Cartridges

14.5.4.2.3.2. Analyzers

14.5.4.2.4.  Clinical Chemistry

14.5.4.2.4.1. Clinical Chemistry Analyzers

14.5.4.2.4.2. Glucose monitoring

14.5.4.2.4.3. Blood gas and electrolyte analysis

14.5.4.2.5.  Others

14.5.4.3.  Kuwait Veterinary Diagnostic Market Revenue (US$ Mn) and Forecasts, By Species

14.5.4.3.1.  Companion animals

14.5.4.3.1.1. Cat

14.5.4.3.1.2. Dogs

14.5.4.3.1.3. Others

14.5.4.3.2.  Farm animals

14.5.4.3.2.1. Cattle

14.5.4.3.2.2. Swine

14.5.4.3.2.3. Poultry

14.5.4.3.2.4. Horse

14.5.4.3.2.5. Others

14.5.5. South Africa

14.5.5.1.  South Africa Veterinary Diagnostic Market Revenue (US$ Mn) and Forecasts, By Product

14.5.5.1.1.  Instruments

14.5.5.1.2.  Consumables

14.5.5.2.  South Africa Veterinary Diagnostic Market Revenue (US$ Mn) and Forecasts, By Technology

14.5.5.2.1.  Immunodiagnostic

14.5.5.2.1.1. Lateral flow assays

14.5.5.2.1.2. ELISA

14.5.5.2.1.3. Immunoassay analyzers

14.5.5.2.1.4. Others

14.5.5.2.2.  Molecular Diagnostic

14.5.5.2.2.1. Polymerase Chain Reaction (PCR)

14.5.5.2.2.2. Microarrays

14.5.5.2.2.3. Others

14.5.5.2.3.  Hematology

14.5.5.2.3.1. Cartridges

14.5.5.2.3.2. Analyzers

14.5.5.2.4.  Clinical Chemistry

14.5.5.2.4.1. Clinical Chemistry Analyzers

14.5.5.2.4.2. Glucose monitoring

14.5.5.2.4.3. Blood gas and electrolyte analysis

14.5.5.2.5.  Others

14.5.5.3.  South Africa Veterinary Diagnostic Market Revenue (US$ Mn) and Forecasts, By Species

14.5.5.3.1.  Companion animals

14.5.5.3.1.1. Cat

14.5.5.3.1.2. Dogs

14.5.5.3.1.3. Others

14.5.5.3.2.  Farm animals

14.5.5.3.2.1. Cattle

14.5.5.3.2.2. Swine

14.5.5.3.2.3. Poultry

14.5.5.3.2.4. Horse

14.5.5.3.2.5. Others

14.5.6. Rest of Middle East & Africa

14.5.6.1.  Rest of Middle East & Africa Veterinary Diagnostic Market Revenue (US$ Mn) and Forecasts, By Product

14.5.6.1.1.  Instruments

14.5.6.1.2.  Consumables

14.5.6.2.  Rest of Middle East & Africa Veterinary Diagnostic Market Revenue (US$ Mn) and Forecasts, By Technology

14.5.6.2.1.  Immunodiagnostic

14.5.6.2.1.1. Lateral flow assays

14.5.6.2.1.2. ELISA

14.5.6.2.1.3. Immunoassay analyzers

14.5.6.2.1.4. Others

14.5.6.2.2.  Molecular Diagnostic

14.5.6.2.2.1. Polymerase Chain Reaction (PCR)

14.5.6.2.2.2. Microarrays

14.5.6.2.2.3. Others

14.5.6.2.3.  Hematology

14.5.6.2.3.1. Cartridges

14.5.6.2.3.2. Analyzers

14.5.6.2.4.  Clinical Chemistry

14.5.6.2.4.1. Clinical Chemistry Analyzers

14.5.6.2.4.2. Glucose monitoring

14.5.6.2.4.3. Blood gas and electrolyte analysis

14.5.6.2.5.  Others

14.5.6.3.  Rest of Middle East & Africa Veterinary Diagnostic Market Revenue (US$ Mn) and Forecasts, By Species

14.5.6.3.1.  Companion animals

14.5.6.3.1.1. Cat

14.5.6.3.1.2. Dogs

14.5.6.3.1.3. Others

14.5.6.3.2.  Farm animals

14.5.6.3.2.1. Cattle

14.5.6.3.2.2. Swine

14.5.6.3.2.3. Poultry

14.5.6.3.2.4. Horse

14.5.6.3.2.5. Others

14.6. Key Segment for Channeling Investments

14.6.1. By Country

14.6.2. By Product

14.6.3. By Technology

14.6.4. By Species

15. Latin America Veterinary Diagnostic Market Analysis and Forecasts, 2019 - 2027

15.1. Overview

15.1.1. Latin America Veterinary Diagnostic Market Revenue (US$ Mn)

15.2. Latin America Veterinary Diagnostic Market Revenue (US$ Mn) and Forecasts, By Product

15.2.1. Instruments

15.2.2. Consumables

15.3. Latin America Veterinary Diagnostic Market Revenue (US$ Mn) and Forecasts, By Technology

15.3.1. Immunodiagnostic

15.3.1.1.  Lateral flow assays

15.3.1.2.  ELISA

15.3.1.3.  Immunoassay analyzers

15.3.1.4.  Others

15.3.2. Molecular Diagnostic

15.3.2.1.  Polymerase Chain Reaction (PCR)

15.3.2.2.  Microarrays

15.3.2.3.  Others

15.3.3. Hematology

15.3.3.1.  Cartridges

15.3.3.2.  Analyzers

15.3.4. Clinical Chemistry

15.3.4.1.  Clinical Chemistry Analyzers

15.3.4.2.  Glucose monitoring

15.3.4.3.  Blood gas and electrolyte analysis

15.3.5. Others

15.4. Latin America Veterinary Diagnostic Market Revenue (US$ Mn) and Forecasts, By Species

15.4.1. Companion animals

15.4.1.1.  Cat

15.4.1.2.  Dogs

15.4.1.3.  Others

15.4.2. Farm animals

15.4.2.1.  Cattle

15.4.2.2.  Swine

15.4.2.3.  Poultry

15.4.2.4.  Horse

15.4.2.5.  Others

15.5. Latin America Veterinary Diagnostic Market Revenue (US$ Mn) and Forecasts, By Country

15.5.1. Brazil

15.5.1.1.  Brazil Veterinary Diagnostic Market Revenue (US$ Mn) and Forecasts, By Product

15.5.1.1.1.  Instruments

15.5.1.1.2.  Consumables

15.5.1.2.  Brazil Veterinary Diagnostic Market Revenue (US$ Mn) and Forecasts, By Technology

15.5.1.2.1.  Immunodiagnostic

15.5.1.2.1.1. Lateral flow assays

15.5.1.2.1.2. ELISA

15.5.1.2.1.3. Immunoassay analyzers

15.5.1.2.1.4. Others

15.5.1.2.2.  Molecular Diagnostic

15.5.1.2.2.1. Polymerase Chain Reaction (PCR)

15.5.1.2.2.2. Microarrays

15.5.1.2.2.3. Others

15.5.1.2.3.  Hematology

15.5.1.2.3.1. Cartridges

15.5.1.2.3.2. Analyzers

15.5.1.2.4.  Clinical Chemistry

15.5.1.2.4.1. Clinical Chemistry Analyzers

15.5.1.2.4.2. Glucose monitoring

15.5.1.2.4.3. Blood gas and electrolyte analysis

15.5.1.2.5.  Others

15.5.1.3.  Brazil Veterinary Diagnostic Market Revenue (US$ Mn) and Forecasts, By Species

15.5.1.3.1.  Companion animals

15.5.1.3.1.1. Cat

15.5.1.3.1.2. Dogs

15.5.1.3.1.3. Others

15.5.1.3.2.  Farm animals

15.5.1.3.2.1. Cattle

15.5.1.3.2.2. Swine

15.5.1.3.2.3. Poultry

15.5.1.3.2.4. Horse

15.5.1.3.2.5. Others

15.5.2. Argentina

15.5.2.1.  Argentina Veterinary Diagnostic Market Revenue (US$ Mn) and Forecasts, By Product

15.5.2.1.1.  Instruments

15.5.2.1.2.  Consumables

15.5.2.2.  Argentina Veterinary Diagnostic Market Revenue (US$ Mn) and Forecasts, By Technology

15.5.2.2.1.  Immunodiagnostic

15.5.2.2.1.1. Lateral flow assays

15.5.2.2.1.2. ELISA

15.5.2.2.1.3. Immunoassay analyzers

15.5.2.2.1.4. Others

15.5.2.2.2.  Molecular Diagnostic

15.5.2.2.2.1. Polymerase Chain Reaction (PCR)

15.5.2.2.2.2. Microarrays

15.5.2.2.2.3. Others

15.5.2.2.3.  Hematology

15.5.2.2.3.1. Cartridges

15.5.2.2.3.2. Analyzers

15.5.2.2.4.  Clinical Chemistry

15.5.2.2.4.1. Clinical Chemistry Analyzers

15.5.2.2.4.2. Glucose monitoring

15.5.2.2.4.3. Blood gas and electrolyte analysis

15.5.2.2.5.  Others

15.5.2.3.  Argentina Veterinary Diagnostic Market Revenue (US$ Mn) and Forecasts, By Species

15.5.2.3.1.  Companion animals

15.5.2.3.1.1. Cat

15.5.2.3.1.2. Dogs

15.5.2.3.1.3. Others

15.5.2.3.2.  Farm animals

15.5.2.3.2.1. Cattle

15.5.2.3.2.2. Swine

15.5.2.3.2.3. Poultry

15.5.2.3.2.4. Horse

15.5.2.3.2.5. Others

15.5.3. Rest of Latin America

15.5.3.1.  Rest of Latin America Veterinary Diagnostic Market Revenue (US$ Mn) and Forecasts, By Product

15.5.3.1.1.  Instruments

15.5.3.1.2.  Consumables

15.5.3.2.  Rest of Latin America Veterinary Diagnostic Market Revenue (US$ Mn) and Forecasts, By Technology

15.5.3.2.1.  Immunodiagnostic

15.5.3.2.1.1. Lateral flow assays

15.5.3.2.1.2. ELISA

15.5.3.2.1.3. Immunoassay analyzers

15.5.3.2.1.4. Others

15.5.3.2.2.  Molecular Diagnostic

15.5.3.2.2.1. Polymerase Chain Reaction (PCR)

15.5.3.2.2.2. Microarrays

15.5.3.2.2.3. Others

15.5.3.2.3.  Hematology

15.5.3.2.3.1. Cartridges

15.5.3.2.3.2. Analyzers

15.5.3.2.4.  Clinical Chemistry

15.5.3.2.4.1. Clinical Chemistry Analyzers

15.5.3.2.4.2. Glucose monitoring

15.5.3.2.4.3. Blood gas and electrolyte analysis

15.5.3.2.5.  Others

15.5.3.3.  Rest of Latin America Veterinary Diagnostic Market Revenue (US$ Mn) and Forecasts, By Species

15.5.3.3.1.  Companion animals

15.5.3.3.1.1. Cat

15.5.3.3.1.2. Dogs

15.5.3.3.1.3. Others

15.5.3.3.2.  Farm animals

15.5.3.3.2.1. Cattle

15.5.3.3.2.2. Swine

15.5.3.3.2.3. Poultry

15.5.3.3.2.4. Horse

15.5.3.3.2.5. Others

15.6. Key Segment for Channeling Investments

15.6.1. By Country

15.6.2. By Product

15.6.3. By Technology

15.6.4. By Species

16. Competitive Benchmarking

16.1. Brand Benchmarking

16.2. Market Share Analysis, 2018

16.3. Global Presence and Growth Strategies

16.3.1. Mergers and Acquisitions

16.3.2. Product Launches

16.3.3. Investments Trends

16.3.4. R&D Initiatives

17. Player Profiles

17.1. Abaxis, Inc.

17.1.1. Company Details

17.1.2. Company Overview

17.1.3. Product Offerings

17.1.4. Key Developments

17.1.5. Financial Analysis

17.1.6. SWOT Analysis

17.1.7. Business Strategies

17.2. Agrolabo S.p.A.

17.2.1. Company Details

17.2.2. Company Overview

17.2.3. Product Offerings

17.2.4. Key Developments

17.2.5. Financial Analysis

17.2.6. SWOT Analysis

17.2.7. Business Strategies

17.3. Bio-X Diagnostics S.A.

17.3.1. Company Details

17.3.2. Company Overview

17.3.3. Product Offerings

17.3.4. Key Developments

17.3.5. Financial Analysis

17.3.6. SWOT Analysis

17.3.7. Business Strategies

17.4. Eurolyser Diagnostica

17.4.1. Company Details

17.4.2. Company Overview

17.4.3. Product Offerings

17.4.4. Key Developments

17.4.5. Financial Analysis

17.4.6. SWOT Analysis

17.4.7. Business Strategies

17.5. Heska Corporation

17.5.1. Company Details

17.5.2. Company Overview

17.5.3. Product Offerings

17.5.4. Key Developments

17.5.5. Financial Analysis

17.5.6. SWOT Analysis

17.5.7. Business Strategies

17.6. ID.vet

17.6.1. Company Details

17.6.2. Company Overview

17.6.3. Product Offerings

17.6.4. Key Developments

17.6.5. Financial Analysis

17.6.6. SWOT Analysis

17.6.7. Business Strategies

17.7. Indical Bioscience GmbH

17.7.1. Company Details

17.7.2. Company Overview

17.7.3. Product Offerings

17.7.4. Key Developments

17.7.5. Financial Analysis

17.7.6. SWOT Analysis

17.7.7. Business Strategies

17.8. Ingenasa

17.8.1. Company Details

17.8.2. Company Overview

17.8.3. Product Offerings

17.8.4. Key Developments

17.8.5. Financial Analysis

17.8.6. SWOT Analysis

17.8.7. Business Strategies

17.9. Megacor Diagnostik GmbH

17.9.1. Company Details

17.9.2. Company Overview

17.9.3. Product Offerings

17.9.4. Key Developments

17.9.5. Financial Analysis

17.9.6. SWOT Analysis

17.9.7. Business Strategies

17.10. Neogen Corporation

17.10.1. Company Details

17.10.2. Company Overview

17.10.3. Product Offerings

17.10.4. Key Developments

17.10.5. Financial Analysis

17.10.6. SWOT Analysis

17.10.7. Business Strategies

17.11. Qiagen N.V.

17.11.1. Company Details

17.11.2. Company Overview

17.11.3. Product Offerings

17.11.4. Key Developments

17.11.5. Financial Analysis

17.11.6. SWOT Analysis

17.11.7. Business Strategies

17.12. Randox Laboratories – US Ltd

17.12.1. Company Details

17.12.2. Company Overview

17.12.3. Product Offerings

17.12.4. Key Developments

17.12.5. Financial Analysis

17.12.6. SWOT Analysis

17.12.7. Business Strategies

17.13. URIT Medical Electronic Group Co., Ltd.

17.13.1. Company Details

17.13.2. Company Overview

17.13.3. Product Offerings

17.13.4. Key Developments

17.13.5. Financial Analysis

17.13.6. SWOT Analysis

17.13.7. Business Strategies

17.14. Virbac Corporation

17.14.1. Company Details

17.14.2. Company Overview

17.14.3. Product Offerings

17.14.4. Key Developments

17.14.5. Financial Analysis

17.14.6. SWOT Analysis

17.14.7. Business Strategies

17.15. Zoetis Inc

17.15.1. Company Details

17.15.2. Company Overview

17.15.3. Product Offerings

17.15.4. Key Developments

17.15.5. Financial Analysis

17.15.6. SWOT Analysis

17.15.7. Business Strategies

17.16. Other market participants

18. Key Findings:

 

Note: This ToC is tentative and can be changed according to the research study conducted during the course of report completion.

 

**Exclusive for Multi-User and Enterprise User.

At Absolute Markets Insights, we are engaged in building both global as well as country specific reports. As a result, the approach taken for deriving the estimation and forecast for a specific country is a bit unique and different in comparison to the global research studies. In this case, we not only study the concerned market factors & trends prevailing in a particular country (from secondary research) but we also tend to calculate the actual market size & forecast from the revenue generated from the market participants involved in manufacturing or distributing the any concerned product. These companies can also be service providers. For analyzing any country specifically, we do consider the growth factors prevailing under the states/cities/county for the same. For instance, if we are analyzing an industry specific to United States, we primarily need to study about the states present under the same(where the product/service has the highest growth). Similar analysis will be followed by other countries. Our scope of the report changes with different markets.

Our research study is mainly implement through a mix of both secondary and primary research. Various sources such as industry magazines, trade journals, and government websites and trade associations are reviewed for gathering precise data. Primary interviews  are conducted to validate the market size derived from secondary research. Industry experts, major manufacturers and distributors are contacted for further validation purpose on the current market penetration and growth trends.  

Prominent participants in our primary research process include:

• Key Opinion Leaders namely the CEOs, CSOs, VPs, purchasing managers, amongst others
• Research and development participants, distributors/suppliers and subject matter experts

Secondary Research includes data extracted from paid data sources:

• Reuters
• Factiva
• Bloomberg
• One Source
• Hoovers

Research Methodology

Key Inclusions